Walleye Trading’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$112K Sell
343
-3,017
-90% -$984K ﹤0.01% 711
2025
Q1
$907K Buy
+3,360
New +$907K ﹤0.01% 358
2024
Q4
Hold
0
1075
2024
Q3
Sell
-1,318
Closed -$320K 1223
2024
Q2
$320K Sell
1,318
-23,854
-95% -$5.8M ﹤0.01% 705
2024
Q1
$3.76M Buy
25,172
+2,661
+12% +$398K 0.01% 206
2023
Q4
$4.31M Buy
+22,511
New +$4.31M 0.01% 236
2023
Q3
Sell
-4,489
Closed -$853K 1704
2023
Q2
$853K Sell
4,489
-1,548
-26% -$294K ﹤0.01% 375
2023
Q1
$1.21M Buy
+6,037
New +$1.21M ﹤0.01% 295
2022
Q4
Sell
-28,223
Closed -$5.65M 1698
2022
Q3
$5.65M Buy
28,223
+16,154
+134% +$3.23M 0.02% 114
2022
Q2
$1.76M Buy
+12,069
New +$1.76M 0.01% 295
2022
Q1
Sell
-3,305
Closed -$560K 1920
2021
Q4
$560K Buy
3,305
+1,705
+107% +$289K ﹤0.01% 729
2021
Q3
$302K Sell
1,600
-651
-29% -$123K ﹤0.01% 891
2021
Q2
$382K Buy
2,251
+1,597
+244% +$271K ﹤0.01% 844
2021
Q1
$92K Sell
654
-765
-54% -$108K ﹤0.01% 1275
2020
Q4
$184K Buy
+1,419
New +$184K ﹤0.01% 965
2020
Q3
Hold
0
1052
2020
Q2
Sell
-11,048
Closed -$1.2M 1118
2020
Q1
$1.2M Buy
+11,048
New +$1.2M 0.01% 240
2019
Q4
Sell
-2,986
Closed -$240K 1266
2019
Q3
$240K Sell
2,986
-34
-1% -$2.73K ﹤0.01% 688
2019
Q2
$219K Buy
+3,020
New +$219K ﹤0.01% 695
2019
Q1
Sell
-5,236
Closed -$382K 1091
2018
Q4
$382K Sell
5,236
-3,967
-43% -$289K ﹤0.01% 744
2018
Q3
$805K Buy
9,203
+4,589
+99% +$401K ﹤0.01% 602
2018
Q2
$454K Buy
+4,614
New +$454K ﹤0.01% 766
2015
Q4
Sell
-300
Closed -$24K 1875
2015
Q3
$24K Buy
300
+200
+200% +$16K ﹤0.01% 1203
2015
Q2
$12K Buy
+100
New +$12K ﹤0.01% 1257